Embody vs Luvo Health
In our scoring, Embody edges ahead overall (7.8 vs 7.5 out of 10), and Embody costs less for compounded semaglutide (about $1,379 a year less; one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost).
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Key differences
- Price
- Embody $79/mo vs Luvo Health $179/mo for compounded semaglutide (standing prices, no prepay or separate membership listed · about $1,379 a year less with Embody · one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- Coverage
- Embody 50 states (Luvo Health doesn't publish a state list)
- Included
- Embody: medication, clinician visits, shipping; Luvo Health: medication, clinician visits, shipping
Embody
Affiliate partnerBest for low flat-rate compounded GLP-1 pricing at every dose
semaglutide
$79
Our score 7.8/10
Luvo Health
Affiliate partnerBest for compounded and brand GLP-1s, oral tablets and microdosing on one public price list
semaglutide
$179
billed every 4 weeks · $99 first month
Our score 7.5/10
We may earn a commission if you sign up through these links. Partner status can affect which provider we feature; it never changes a score or a price.
Costs & coverage
Published prices with their terms attached. Yearly figures are modeled from the standing price and billing cadence. A check mark marks the better side, on like-for-like rows only.
Embody
Luvo Health
Price
Semaglutide / month
Better on this row: $79/mo
$179/mo
billed every 4 weeks · $99 first month
Semaglutide / year (modeled)
Better on this row: $948
$2,327
13 charges
Tirzepatide / month
Better on this row: $129/mo
$179/mo
billed every 4 weeks · $99 first month
Tirzepatide / year (modeled)
Better on this row: $1,548
$2,327
13 charges
Oral semaglutide / month
$229/mo
Better on this row: $179/mo
billed every 4 weeks · $99 first month
Oral semaglutide / year (modeled)
$2,748
Better on this row: $2,327
13 charges
Oral tirzepatide / month
$329/mo
Not listed
Brand Wegovy / Ozempic / month
Not listed
$1,299/mo
billed every 4 weeks
Brand Zepbound / Mounjaro / month
Not listed
$1,399/mo
billed every 4 weeks
Coverage
State availability
50 states
List not published
Oral option listed
Yes
Yes
Brand-name access listed
Not listed
Wegovy / Ozempic, Zepbound / Mounjaro
Included in the price
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Terms & safety
Price shown
Before intake
Before intake
Lab work
Not required
Not disclosed
Video visit
Not required
Not disclosed
Cancel anytime
Not disclosed
Yes
Minimum commitment
Not disclosed
None on the 4-week plan; the pricing page mentions plans up to 24 weeks but publishes only 4-week prices
Refunds
Refund only if disqualified; 6-mo guarantee
You may request or be issued a refund for your current billing cycle only if, at the time of the request or cancellation, your medication has not been ordered.
Early-cancellation fee
Not disclosed
None
FDA warning letters
None on record
None on record
Provider facts checked
August 2026
October 2026
Every dose and plan: Embody · Luvo Health
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 540+ providers' prices on their own sites and email you when tracked prices move.
Which fits your priorities?
Only the points where these two differ, from the table above and each provider’s record.
Choose Embody if…
- About $1,379 a year less than Luvo Health for compounded semaglutide at standing prices (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- Lists oral compounded tirzepatide, which Luvo Health doesn't price
- Publishes its full state list (50 states)
What to weigh up
- The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored
- Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
Choose Luvo Health if…
- Lists brand-name Wegovy / Ozempic and brand-name Zepbound / Mounjaro, which Embody doesn't price
- Every medication's 4-week price is published openly, with no intake or account needed
- Offers both compounded GLP-1s and brand-name Ozempic and Zepbound in one place
What to weigh up
- About $1,379 a year more than Embody for compounded semaglutide (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
- No published state list; confirm yours at signup
Explore the scoring factors
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Embody
7.8/10
Luvo Health
7.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Embody vs Luvo Health: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Embody and Luvo Health head-to-heads in the same category.
- Embody vs Amazon One Medical
- Embody vs Vytora Health
- Embody vs CoreAge Rx
- Luvo Health vs Amazon One Medical
- Luvo Health vs Vytora Health
- Luvo Health vs CoreAge Rx
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.